MediWound Ltd Asset Resilience Ratio

Latest as of December 2025: 56.04%

MediWound Ltd asset resilience ratio. MediWound Ltd (M8W) has an Asset Resilience Ratio of 56.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See M8W cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€48.34 Million

≈ $56.52 Million USD Cash + Short-term Investments

Total Assets

€86.25 Million

≈ $100.84 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of MediWound Ltd (2016–2025)

Asset resilience ratio of MediWound Ltd from 2016 to 2025. This chart shows how MediWound Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of MediWound Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down MediWound Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see M8W current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€48.34 Million	56.04%
Total Liquid Assets	€48.34 Million	56.04%

Asset Resilience Insights

Very High Liquidity: MediWound Ltd maintains exceptional liquid asset reserves at 56.04% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

MediWound Ltd Industry Peers by Asset Resilience Ratio

Compare MediWound Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

MediWound Ltd Asset Resilience Ratio by Year (2016–2025)

MediWound Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for MediWound Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	56.04%	€48.34 Million ≈ $56.52 Million	€86.25 Million ≈ $100.84 Million	+9.78pp
2024-12-31	46.27%	€34.01 Million ≈ $39.76 Million	€73.50 Million ≈ $85.92 Million	+1.62pp
2023-12-31	44.65%	€29.68 Million ≈ $34.69 Million	€66.46 Million ≈ $77.70 Million	--
2022-12-31	0.00%	€0.00 ≈ $0.00	€50.02 Million ≈ $58.47 Million	--
2021-12-31	0.00%	€0.00 ≈ $0.00	€19.74 Million ≈ $23.08 Million	--
2020-12-31	12.95%	€4.02 Million ≈ $4.70 Million	€31.07 Million ≈ $36.32 Million	-41.34pp
2019-12-31	54.29%	€22.04 Million ≈ $25.76 Million	€40.59 Million ≈ $47.45 Million	+6.33pp
2018-12-31	47.96%	€16.92 Million ≈ $19.78 Million	€35.28 Million ≈ $41.24 Million	--
2017-12-31	0.00%	€0.00 ≈ $0.00	€44.13 Million ≈ $51.60 Million	--
2016-12-31	3.25%	€1.16 Million ≈ $1.36 Million	€35.76 Million ≈ $41.81 Million	--

pp = percentage points

About MediWound Ltd

F:M8W Germany Biotechnology

Market Cap

$172.79 Million

€147.80 Million EUR

Market Cap Rank

#16929 Global

#1599 in Germany

Share Price

€11.50

Change (1 day)

-10.16%

52-Week Range

€10.40 - €17.00

All Time High

€19.60